DELENA YOUNG: Open Payments
NPI 1225290315 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 57 payments from 10 companies in 2025. Trend: 2023 $953 · 2024 $299 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $248 |
| Alkermes, Inc. | 13 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $152 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| ABBVIE INC. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Braeburn Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: INGREZZA, CAPLYTA, ARISTADA, COBENFY, VRAYLAR, REXULTI, LYBALVI, Auvelity.
Industry payments across KY — which companies pay providers there.
